Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 370 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Asthma in Children Clear all

Conditions: Asthma
Interventions: Dupilumab (SAR231893/REGN668), Asthma controller therapies (incl. prednisone/prednisolone), Asthma reliever therapies; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 12
States / cities: Gilbert, Arizona • Tucson, Arizona • Rolling Hills Estates, California + 9 more

Conditions: Asthma
Interventions: Beclomethasone dipropionate, Albuterol sulfate; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 6 Years to 18 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 6
States / cities: Tucson, Arizona • Los Angeles, California • San Diego, California + 3 more

Conditions: Asthma, Cockroach Hypersensitivity
Interventions: Glycerinated German Cockroach Allergenic Extract; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 8 Years to 55 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 4
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • Cincinnati, Ohio + 1 more

Conditions: Sickle Cell Disease, Asthma, Acute Chest Syndrome
Interventions: Budesonide inhalation suspension; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 1 Year to 4 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Asthma
Interventions: Pediatric ASTHMA-Educator mobile application; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 7 Years to 17 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Asthma
Interventions: Fevipiprant; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 6
States / cities: Minneapolis, Minnesota • Columbia, Missouri • Tulsa, Oklahoma + 3 more

Conditions: Pediatric Asthma
Interventions: CASE in person version (High Intensity Package), CASE-V remote version (Low Intensity Package), CASE and HARP in person (High Intensity package), CASE-V and HARP-V remote version (Low Intensity package); Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 2 Years to 12 Years
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Status Asthmaticus
Interventions: Ipratropium, 0.9% Sodium Chloride, Albuterol, corticosteroids; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 2 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Asthma in Children
Interventions: Not listed
Lead sponsor: Atlantic Health System; Other
Eligibility: 6 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Atopic Dermatitis, Ichthyosis, Psoriasis
Interventions: Itch Questionnaire and Interview, Stigma Questionnaire and Interview, Cognitive Interview and PROMIS Itch Questionnaire; Other
Lead sponsor: Northwestern University; Other
Eligibility: 0 Years to 17 Years
Enrollment: 943 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: Coaching, providing social support; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2002
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Asthma, Adherence, Medication, Childhood Asthma
Interventions: CapMedic smart inhaler device, Video-based guidance; Device · Behavioral
Lead sponsor: Landon Pediatric Foundation; Other
Eligibility: 8 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Ventura, California

Conditions: Asthma
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 5 Years to 17 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Asthma
Interventions: Inhaled corticosteroids, eNO measurement; Drug · Procedure
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 12 Years to 20 Years
Enrollment: 547 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 12
States / cities: Tucson, Arizona • Denver, Colorado • Washington D.C., District of Columbia + 9 more

Conditions: Asthma
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Years to 17 Years
Enrollment: 310 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 8
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • Chicago, Illinois + 3 more

Conditions: Asthma in Children
Interventions: Social Media Enhanced Education, Usual Asthma Education; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 3 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Asthma, Hypertension, Obesity
Interventions: Asthma education; Behavioral
Lead sponsor: Duquesne University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 231 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Asthma
Interventions: PIPA Intervention Bundle 1, PIPA Intervention Bundle 2; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 303 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Asthma
Interventions: Racemic albuterol (R+S albuterol), Levalbuterol (R albuterol); Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years to 18 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Status Asthmaticus
Interventions: Blood draw; Procedure
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 2 Years to 18 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Wheezing, Asthma in Children
Interventions: Soy isoflavone, matching placebo; Drug
Lead sponsor: Rajesh Kumar; Other
Eligibility: 2 Months to 12 Months
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Asthma in Children, Humans, Hispanic Americans, Child
Interventions: SmartInhaler with reminder function turned on, SmartInhaler; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 5 Years to 17 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Asthma
Interventions: Prednisolone high dose, Prednisolone lower dose; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Years to 18 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Asthma, Quality of Life, Children
Interventions: Asthma Education Sessions, Asthma Health Assessment via Telemonitoring, Provider Treatment Prompt, School Absenteeism, Prescription Filling Profile; Other
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 7 Years to 14 Years
Enrollment: 823 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Little Rock, Arkansas

Search by objective public record fields.

Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

Cockroach Nasal Allergen Challenge Pilot

Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial

Pediatric ASTHMA-Educator

Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus

Exhaled Nitric Oxide and Airway Caliber in Children With Asthma

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

Coaching in Childhood Asthma

Evaluating Efficacy of Smart Device in Assisting With Inhaler Technique and Adherence

Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With Asthma

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents

Protocol CAUSE-03 / CHEETAH

Using Social Media to Decrease Healthcare Utilization for Pediatric Asthma

Implementation of an Asthma Program to Improve Asthma Identification and Education in Children

Implementing Pathways to Improve Pediatric Asthma Care

Continuous Levalbuterol for Treatment of Status Asthmaticus in Children

B2-Adrenergic Receptor Polymorphisms

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

Interventions To Help Asthma Clinical Adherence

Oral Prednisolone Dosing in Children Hospitalized With Asthma

Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children